Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1994;25:2153-2158

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Venketasubramanian, N.
Right arrow Articles by Piomelli, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Venketasubramanian, N.
Right arrow Articles by Piomelli, S.

Stroke, Vol 25, 2153-2158, Copyright © 1994 by American Heart Association


ARTICLES

Middle cerebral artery velocity changes during transfusion in sickle cell anemia

N Venketasubramanian, I Prohovnik, A Hurlet, JP Mohr and S Piomelli
Department of Neurology, Columbia-Presbyterian Medical Center, New York, NY.

BACKGROUND AND PURPOSE: Sickle cell disease is associated with cerebral hyperemia, which is therapeutically reduced by transfusion; however, the process of transfusion-induced cerebral perfusion changes has heretofore not been observed. METHODS: We document the acute changes of intracranial arterial velocity in 10 patients (7 with strokes, 3 without) undergoing transfusion therapy using transcranial Doppler ultrasonography. Middle cerebral artery velocities were bilaterally measured every 30 minutes for the duration of transfusion (4 to 5 hours). Regional cerebral blood flow was quantified in 5 of these patients before the transfusion and 24 hours later by the 133Xe technique. RESULTS: Velocities in stroke-associated vessels (64.33 +/- 18.65 cm/s; n = 6) were significantly lower than in uninfarcted territories (99.54 +/- 27.39 cm/s; n = 13), and both types of vessels showed a robust reduction of blood flow velocities during transfusion. The rates of reduction were not significantly different as a function of prior stroke but did correlate with pretransfusion velocities and with the rise in hematocrit (multiple r = .887, P < .001). These reductions occurred rapidly within the first 3 hours of transfusion. Velocities attained at the end of transfusion were maintained in the hour after transfusion and the next day. CONCLUSIONS: We conclude that transfusion induces rapid changes in cerebral hemodynamics that are related to pretransfusion velocities and a rise in hematocrit. Transcranial Doppler provides a safe, simple, and noninvasive technique of monitoring these changes and may provide a means of making therapeutic decisions regarding transfusion therapy in patients with sickle cell anemia.


This article has been cited by other articles:


Home page
BloodHome page
S. A. Zimmerman, W. H. Schultz, S. Burgett, N. A. Mortier, and R. E. Ware
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia
Blood, August 1, 2007; 110(3): 1043 - 1047.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. T. Lee, S. Piomelli, S. Granger, S. T. Miller, S. Harkness, D. J. Brambilla, R. J. Adams, and for the STOP Study Investigators
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results
Blood, August 1, 2006; 108(3): 847 - 852.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. R. Powars
Childhood stroke frequency decreased in California during 1999 and 2000
Blood, July 15, 2004; 104(2): 298 - 299.
[Full Text] [PDF]